German Officials Concerned for Vaxx Status of Ukrainian Refugees
Officials in one region in Germany have expressed concern regarding the possible low level of COVID-19 vaccination among Ukrainian refugees.

Officials in one region in Germany have expressed concern regarding the possible low level of COVID-19 vaccination among Ukrainian refugees.
The Chinese company Sinovac Biotech claimed on Wednesday that a third “booster” shot of its coronavirus vaccine product, “Coronavac,” would “effectively enhance the vaccine’s neutralizing capacity to the Omicron variant.”
The Chinese government newspaper Global Times claimed in a report on Tuesday that an experimental vaccine product by the small Chinese company CanSinoBIO “can provide a decent level of protection” against the Omicron variant of Chinese coronavirus.
China’s state-run Global Times dismissed the mRNA technology vaccines against Chinese coronavirus used in America as too “high-priced” and “complicated” for Africa on Monday, shortly before dictator Xi Jinping announced China would give the continent 1 billion doses of its low-quality alternatives.
Singapore, which has a Chinese coronavirus vaccination rate of 82 percent, recorded its highest single-day increase in new locally transmitted cases of the virus Tuesday with 3,994 infections.
Chinese police detained Jiang Yanhong, a 44-year-old single mother living in China’s central Henan province, this weekend after pleading with local officials to investigate the death of her 12-year-old daughter Li Boyi, who died in August after receiving a coronavirus vaccination.
At least 19 Chinese provinces and municipalities are offering booster shots of coronavirus vaccines to combat a recent resurgence of China’s coronavirus caseload nationwide, the state-run Global Times reported Tuesday.
A senior Thai health official said Monday that Thailand will discontinue use of China’s Sinovac coronavirus vaccine after the current supply of the medication is exhausted this week.
China’s state-run Global Times on Tuesday quoted a “new study,” which has not yet been peer-reviewed, that suggested a third does of China’s ineffective Sinovac vaccine could produce a “remarkable increase in antibody levels” and a ‘strong boost in immune response,” bringing Sinovac closer to the quality of competing products such as AstraZeneca’s vaccine.
China’s state-run Global Times on Tuesday touted “Phase II clinical trial data” that suggests the Sinovac coronavirus vaccine is “at least 98.9 percent effective in producing antibodies” when administered to children from 3 to 17 years old. Unfortunately, China’s vaccines have a dubious record of actually preventing coronavirus infections.
The Singapore Ministry of Health announced Tuesday that only individuals who have received the coronavirus vaccine products developed by American companies Pfizer and Moderna will count towards official national vaccination statistics, excluding those who received Chinese-made products.
The Food and Drug Administration (FDA) of Thailand warned Tuesday that it had discovered 110 defective doses of the coronavirus vaccine by Chinese corporation Sinovac Biotech, unusable due to what the media outlet Coconuts described as “lumps of gel” trapped in the dose bottles.
The Communist Party of Cuba celebrated on Sunday the publication of clinical trials allegedly showing that “Soberana 02,” one of four Chinese coronavirus vaccine candidates developed in the country, is 62-percent effective.
An in-depth report published by the Peruvian investigative outlet Ojo Público on Tuesday revealed extensive evidence that at least four Latin American nations — Peru, Argentina, Chile, and Mexico — used spare doses of Chinese-made coronavirus vaccines to immunize politicians and celebrities.
Sinovac Biotech, a Chinese company responsible for the development of one of the least effective Chinese coronavirus vaccines currently in global circulation, suggested on Sunday that patients should receive a third “booster” dose of its product to improve its performance.
Turkish opposition leaders and the general public expressed outrage on Wednesday after Islamist President Recep Tayyip Erdogan claimed that he received a third dose of “Coronavac,” a Chinese-made coronavirus vaccine candidate.
Hong Kong’s Beijing-backed Chief Executive Carrie Lam predicted on Tuesday that residents of the city were so hesitant to receive doses of vaccine candidates for Chinese coronavirus that offering to pay them for it would not change their minds.
President Wavel Ramkalawan of Seychelles, lauded as the world’s most vaccinated country against Chinese coronavirus, defended Chinese-made vaccines on Tuesday despite the fact that their use in his country has failed to prevent a surge in coronavirus cases.
Chinese dictator Xi Jinping has yet to inform the public if he has been inoculated against the Chinese coronavirus or if he plans to, and at press time has not participated in any public efforts to promote his government’s vaccination drive.
Chinese officials announced Tuesday that Chinese companies manufacturing vaccine candidates against the Chinese coronavirus would significantly increase their production capacity to export billions of doses around the world.
The government of Chile defended its decision to trust Chinese vaccine products Sunday after its national vaccination program, one of the world’s most successful, preceded an exponential increase in confirmed coronavirus cases.
The head of China’s Center of Disease Control (CDC), Gao Fu, insisted in an interview Sunday that global media misinterpreted his remarks claiming Chinese-made coronavirus vaccines “don’t have very high protection rates.”
China’s top disease control official admitted Sunday the country’s domestic coronavirus vaccines have low effectiveness and the Communist government is considering how to give them a boost. Chinese vaccines “don’t have very high protection rates,” said the director of the China Centers
Local governments in China are increasingly imposing threatening policies meant to intimidate residents into receiving doses of Chinese-made coronavirus vaccines, resulting in at least one town issuing an official apology after threatening to ban unvaccinated people from supermarkets.
President of Zimbabwe Emmerson Mnangagwa received the Chinese-made coronavirus vaccine candidate “Coronavac” in public on Wednesday to help dispel vaccine “conspiracy theories” that the shot is unsafe.
Two more people died in Hong Kong this week shortly after receiving doses of the Chinese-made coronavirus vaccine candidate “Coronavac,” bringing the number of Hong Kong deaths unofficially tied to it to nine.
Chinese biotech firm Sinovac Life Sciences claimed in a regulatory filing on Monday its coronavirus vaccine is “safe and effective for ages three to 17.”
Concerns have grown in Pakistan about growing public distrust in coronavirus vaccines after Prime Minister Imran Khan revealed this weekend that he tested positive for Chinese coronavirus, two days after receiving his first dose of the made-in-China coronavirus vaccine candidate by Sinopharm.
The number of Hong Kong residents volunteering to receive a dose of Coronavac, a Chinese-made coronavirus vaccine candidate, has dropped from 90 percent to 72 percent following news three people died shortly after receiving the shot this week.
The CEO of Sinovac Biotech, which developed China’s first Chinese coronavirus vaccine, claimed in an interview published Monday that the vaccine is “80-90 percent” effective within two months of receiving two doses.
Two Hong Kong residents died in recent days shortly after receiving doses of ‘CoronaVac,’ a Chinese coronavirus vaccine candidate developed by China’s state-run pharmaceutical company Sinovac Biotech.
Chinese health authorities and state media aggressively defended “Coronavac,” a Chinese coronavirus vaccine candidate by the Chinese firm Sinovac, on Wednesday after a 63-year-old Hong Kong man died this week following the administration of his first dose.
The Chinese pharmaceutical company Sinopharm announced on Wednesday that Phase III clinical trials found their Chinese coronavirus vaccine candidate to be 72.51 percent effective in preventing infections.
The Brazilian municipality of Serrana launched a clinical trial on Wednesday to administer to the town’s entire adult population doses of the Chinese-made coronavirus vaccine candidate CoronaVac.
A University of Hong Kong survey published Thursday revealed a nearly 20-percent drop in interest among Hong Kong residents in receiving any vaccine against the Chinese coronavirus between November and January, and that less than one-third of those living in the city would take a vaccine China developed.
Brazilian President Jair Bolsonaro thanked the Communist Party of China on Monday for their “sensibility” towards Brazil, announcing that his government would import 5,400 liters of ingredients to make “Coronavac,” a Chinese coronavirus candidate by the Chinese firm Sinovac.
A few days after attempting to dismiss disappointing test results from Brazil on China’s Sinovac vaccine candidate for the Chinese coronavirus, Chinese state media turned to attacking Sinovac’s American competitors Pfizer and Moderna, calling for a worldwide ban on Pfizer’s vaccine after 23 elderly Norwegians died, ostensibly from reactions to the Pfizer shots.
Government officials in Indonesia reprimanded local celebrity Raffi Ahmad on Thursday after he was photographed socializing at a private party on Wednesday hours after participating in the Indonesian government’s official coronavirus vaccination campaign.
Indonesian President Joko Widodo received his first dose of CoronaVac, a Chinese-made coronavirus vaccine candidate, on live TV this week.
China’s state-run Global Times on Wednesday put the happiest possible spin on a dismaying Brazilian study that showed China’s Sinovac vaccine candidate for the Chinese coronavirus is only 50 percent effective.